Paper · 8943337
Recombination induced by triple-helix-targeted DNA damage in mammalian cells.
Faruqi AF and 4 others. Mol Cell Biol, 1996. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recombination induced by triple-helix-targeted DNA damage in mammalian cells. Papers, record 8943337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8943337
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Damage | Major topic |
| Genetic Vectors | Major topic |
| Oligonucleotides | Major topic |
| Recombination, Genetic | Major topic |
| Animals | |
| Cell Line | |
| Mammals | |
| Mutation | |
| Nucleic Acid Conformation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA64186 | NCI NIH HHS | United States | R01CA064186 | PubMed and NIH | NIH RePORTER |
| ES05775 | NIEHS NIH HHS | United States | R01ES005775 | PubMed and NIH | NIH RePORTER |
| R29ES005775 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,577,788 | Repair of DNA containing interstrand crosslinks in Escherichia coli: sequential excision and recombination. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4577788 | PubMed |
| 2 | 2,844,801 | Use of psoralen-modified oligonucleotides to trap three-stranded RecA-DNA complexes and repair of these cross-linked complexes by ABC excinuclease. | J Biol Chem | 1988 | https://conductscience.org/library/papers/2844801 | PubMed |
| 3 | 7,026,973 | Repair of interstrand cross-links in DNA of Saccharomyces cerevisiae requires two systems for DNA repair: the RAD3 system and the RAD51 system. | Mol Gen Genet | 1981 | https://conductscience.org/library/papers/7026973 | PubMed |
| 4 | 6,328,502 | Homologous recombination between plasmids in mammalian cells can be enhanced by treatment of input DNA. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6328502 | PubMed |
| 5 | 2,411,210 | Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry. | Annu Rev Biochem | 1985 | https://conductscience.org/library/papers/2411210 | PubMed |
| 6 | 3,002,636 | High frequency targeting of genes to specific sites in the mammalian genome. | Cell | 1986 | https://conductscience.org/library/papers/3002636 | PubMed |
| 7 | 3,534,882 | Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3534882 | PubMed |
| 8 | 3,053,693 | Analysis of sequential steps of nucleotide excision repair in Escherichia coli using synthetic substrates containing single psoralen adducts. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3053693 | PubMed |
| 9 | 3,194,019 | Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. | Nature | 1988 | https://conductscience.org/library/papers/3194019 | PubMed |
| 10 | 3,242,616 | Specificity in formation of triple-stranded nucleic acid helical complexes: studies with agarose-linked polyribonucleotide affinity columns. | Biochemistry | 1988 | https://conductscience.org/library/papers/3242616 | PubMed |
1 to 10 of 51
See all 51 referencesCited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,843,926 | Development and functional evaluation of a psoralen-conjugated nucleoside mimic for triplex-forming oligonucleotides. | Commun Chem | 2025 | https://conductscience.org/library/papers/39843926 | PubMed |
| 38,258,771 | Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects. | Curr Gene Ther | 2024 | https://conductscience.org/library/papers/38258771 | PubMed |
| 37,896,275 | Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896275 | PubMed |
| 34,713,221 | Gene Correction of Point Mutations Using PolyPurine Reverse Hoogsteen Hairpins Technology. | Front Genome Ed | 2020 | https://conductscience.org/library/papers/34713221 | PubMed |
| 32,046,275 | Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair. | Molecules | 2020 | https://conductscience.org/library/papers/32046275 | PubMed |
| 26,506,267 | Origins of Programmable Nucleases for Genome Engineering. | J Mol Biol | 2016 | https://conductscience.org/library/papers/26506267 | PubMed |
| 25,408,401 | Therapeutic genome mutagenesis using synthetic donor DNA and triplex-forming molecules. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25408401 | PubMed |
| 23,014,335 | Local delivery of gene-modifying triplex-forming molecules to the epidermis. | J Invest Dermatol | 2013 | https://conductscience.org/library/papers/23014335 | PubMed |
| 21,686,249 | Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA). | Artif DNA PNA XNA | 2011 | https://conductscience.org/library/papers/21686249 | PubMed |
| 21,501,652 | Triplex technology in studies of DNA damage, DNA repair, and mutagenesis. | Biochimie | 2011 | https://conductscience.org/library/papers/21501652 | PubMed |
1 to 10 of 37
See all 37 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8943337
GET https://conductscience.org/api/papers/v1/8943337/references?page=2